Pan Tumour Nivolumab Rollover Study

Titre officiel

Pan-Tumour Study for Long Term Follow-up of Cancer Survivors Who Have Participated in Trials Investigating Nivolumab

Sommaire:

Main Objective of this study is to examine long-term safety of nivolumab in participants on treatment and in follow up.

Description de l'essai

Primary Outcome:

• Incidence of Adverse Events (AEs)
• Incidence of drug related AEs
• Incidence of AEs leading to Discontinuation
• Incidence of Serious Adverse Events (SAEs)
• Incidence of Select AEs
• Incidence of Immune-Mediated AEs
• Incidence of Death

Voir cet essai sur ClinicalTrials.gov